Net profit of Bal Pharma declined 19.23% to Rs 0.21 crore in the quarter ended June 2025 as against Rs 0.26 crore during the previous quarter ended June 2024. Sales declined 11.42% to Rs 65.87 crore in the quarter ended June 2025 as against Rs 74.36 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 65.87 | 74.36 | -11 |
OPM % | 9.20 | 8.69 | - |
PBDT | 2.73 | 3.05 | -10 |
PBT | 0.21 | 0.62 | -66 |
NP | 0.21 | 0.26 | -19 |